文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The rising burden of diabetes and state-wise variations in India: insights from the Global Burden of Disease Study 1990-2021 and projections to 2031.

作者信息

Chauhan Shubham, Khatib Mahalaqua Nazli, Ballal Suhas, Bansal Pooja, Bhopte Kiran, Gaidhane Abhay M, Tomar Balvir S, Ashraf Ayash, Kumar M Ravi, Chauhan Ashish Singh, Shabil Muhammed, Jena Diptismita, Bushi Ganesh, Satapathy Prakasini, Jain Lara, Jaiswal Vaibhav, Pant Manvi

机构信息

Evidence for Policy and Learning, Global Center for Evidence Synthesis, Chandigarh, India.

Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.

出版信息

Front Endocrinol (Lausanne). 2025 May 12;16:1505143. doi: 10.3389/fendo.2025.1505143. eCollection 2025.


DOI:10.3389/fendo.2025.1505143
PMID:40421244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12104079/
Abstract

BACKGROUND: Diabetes is a major public health concern in India, contributing significantly to morbidity and mortality. With variations in disease burden across states, a detailed understanding of trends in incidence, prevalence, and Disability Adjusted Life Years (DALYs) is essential for targeted interventions. METHODS: This study utilized Global Burden of Disease (GBD) data from 1990 to 2021 to examine trends in diabetes across Indian states. Age-standardized incidence, prevalence, mortality, and DALYs were analyzed using Join point regression to estimate Annual Percentage Change (APC). Autoregressive Integrated Moving Average (ARIMA) models were employed to project diabetes trends up to 2031.While the GBD data provide robust national and regional estimates, their modeled nature may not capture the full spectrum of local epidemiological variations. RESULTS: Diabetes incidence increased from 162.74 to 264.53 per 100,000 between 1990 and 2021, with an APC of 0.63%. Joinpoint analysis identified episodic surges in incidence, with APCs of 2.25% during 1996-1999 and 2.07% during 2005-2011, suggesting intervals of accelerated increase relative to the gradual progression typically observed in chronic conditions. Mortality rose from 23.09 to 31.12 per 100,000 (APC: 0.12%). Southern and Western states, such as Tamil Nadu and Goa, exhibited the highest prevalence and DALYs. Forecasted trends indicate that by 2031, the prevalence will reach 8585.45 per 100,000, and DALYs will exceed 1241.57 per 100,000. CONCLUSION: The burden of diabetes in India has risen markedly over the past three decades. These findings underscore the urgent need for health policies that emphasize lifestyle modifications and improved healthcare access. A comprehensive approach that integrates primary prevention through community-based health education, dietary counseling, and initiatives to promote physical activity with secondary prevention measures such as systematic screening and timely clinical management, is essential for effective diabetes control and management in high-burden states.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/4cbd349793fb/fendo-16-1505143-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/77f33fc2b5fa/fendo-16-1505143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/38c0accba166/fendo-16-1505143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/d6f7e25b1567/fendo-16-1505143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/50fc2bc05374/fendo-16-1505143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/d0b902cab171/fendo-16-1505143-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/53fe06f09674/fendo-16-1505143-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/4cbd349793fb/fendo-16-1505143-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/77f33fc2b5fa/fendo-16-1505143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/38c0accba166/fendo-16-1505143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/d6f7e25b1567/fendo-16-1505143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/50fc2bc05374/fendo-16-1505143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/d0b902cab171/fendo-16-1505143-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/53fe06f09674/fendo-16-1505143-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/12104079/4cbd349793fb/fendo-16-1505143-g007.jpg

相似文献

[1]
The rising burden of diabetes and state-wise variations in India: insights from the Global Burden of Disease Study 1990-2021 and projections to 2031.

Front Endocrinol (Lausanne). 2025-5-12

[2]
The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990-2016.

Lancet Glob Health. 2018-9-12

[3]
Trends and Projections of Early-Onset Colorectal Cancer Burden in China, 1990-2036: Findings From the Global Burden of Disease 2021 Study.

Cancer Control. 2025

[4]
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[5]
Global trends in refractive disorders from 1990 to 2021: insights from the global burden of disease study and predictive modeling.

Front Public Health. 2025-3-26

[6]
Estimation of burden of cancer incidence and mortality in India: based on global burden of disease study 1990-2021.

BMC Cancer. 2024-10-15

[7]
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[8]
Current status, trend changes, and future predictions of the disease burden of type 1 diabetes kidney disease in global and China.

Front Endocrinol (Lausanne). 2025-3-17

[9]
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study.

Diabetes Obes Metab. 2025-4

[10]
Global burden of subarachnoid hemorrhage among adolescents and young adults aged 15-39 years: A trend analysis study from 1990 to 2021.

PLoS One. 2024-12-20

本文引用的文献

[1]
Prevalence of erectile dysfunction among patients with type 2 diabetes mellitus in India: a meta-analysis.

Expert Rev Endocrinol Metab. 2025-2-25

[2]
Correlates of diabetes mellitus and hypertension in India: Change as evidenced from NFHS- 4 and 5 during 2015-2021.

PLoS One. 2024

[3]
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[4]
Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused.

Health Sci Rep. 2024-3-22

[5]
National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021.

JAMA Intern Med. 2023-7-31

[6]
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2023-7-15

[7]
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).

Lancet Diabetes Endocrinol. 2023-7

[8]
Socioeconomic inequality in awareness, treatment and control of diabetes among adults in India: Evidence from National Family Health Survey of India (NFHS), 2019-2021.

Sci Rep. 2023-2-20

[9]
Gender gaps in type 1 diabetes care.

Acta Diabetol. 2023-3

[10]
ARIMA model for predicting chronic kidney disease and estimating its economic burden in China.

BMC Public Health. 2022-12-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索